Literature DB >> 23788618

Diabetic nephropathy: a national dialogue.

Matthew D Breyer1, Thomas M Coffman, Michael F Flessner, Linda F Fried, Raymond C Harris, Christian J Ketchum, Matthias Kretzler, Robert G Nelson, John R Sedor, Katalin Susztak.   

Abstract

The National Institute of Diabetes and Digestive and Kidney Diseases-supported Kidney Research National Dialogue (KRND) asked the scientific community to formulate and prioritize research objectives that would improve our understanding of kidney function and disease. Several high-priority objectives for diabetic nephropathy were identified in data and sample collection, hypothesis generation, hypothesis testing, and translation promotion. The lack of readily available human samples linked to comprehensive phenotypic, clinical, and demographic data remains a significant obstacle. With data and biological samples in place, several possibilities exist for using new technologies to develop hypotheses. Testing novel disease mechanisms with state-of-the-art tools should continue to be the foundation of the investigative community. Research must be translated to improve diagnosis and treatment of people. The objectives identified by the KRND provide the research community with future opportunities for improving the prevention, diagnosis, and treatment of diabetic nephropathy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23788618      PMCID: PMC3805071          DOI: 10.2215/CJN.03640413

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  4 in total

1.  Safety and predictors of complications of renal biopsy in the outpatient setting.

Authors:  S H-T Jiang; K M Karpe; G S Talaulikar
Journal:  Clin Nephrol       Date:  2011-12       Impact factor: 0.975

2.  Identifying genetic susceptibilities to diabetes-related complications among individuals at low risk of complications: An application of tree-structured survival analysis.

Authors:  Tina Costacou; Yuefang Chang; Robert E Ferrell; Trevor J Orchard
Journal:  Am J Epidemiol       Date:  2006-08-23       Impact factor: 4.897

3.  Long-range gene regulation links genomic type 2 diabetes and obesity risk regions to HHEX, SOX4, and IRX3.

Authors:  Anja Ragvin; Enrico Moro; David Fredman; Pavla Navratilova; Øyvind Drivenes; Pär G Engström; M Eva Alonso; Elisa de la Calle Mustienes; José Luis Gómez Skarmeta; Maria J Tavares; Fernando Casares; Miguel Manzanares; Veronica van Heyningen; Anders Molven; Pål R Njølstad; Francesco Argenton; Boris Lenhard; Thomas S Becker
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

Review 4.  Genomically humanized mice: technologies and promises.

Authors:  Anny Devoy; Rosie K A Bunton-Stasyshyn; Victor L J Tybulewicz; Andrew J H Smith; Elizabeth M C Fisher
Journal:  Nat Rev Genet       Date:  2011-12-16       Impact factor: 53.242

  4 in total
  9 in total

1.  FXR/TGR5 Dual Agonist Prevents Progression of Nephropathy in Diabetes and Obesity.

Authors:  Xiaoxin X Wang; Dong Wang; Yuhuan Luo; Komuraiah Myakala; Evgenia Dobrinskikh; Avi Z Rosenberg; Jonathan Levi; Jeffrey B Kopp; Amanda Field; Ashley Hill; Scott Lucia; Liru Qiu; Tao Jiang; Yingqiong Peng; David Orlicky; Gabriel Garcia; Michal Herman-Edelstein; Vivette D'Agati; Kammi Henriksen; Luciano Adorini; Mark Pruzanski; Cen Xie; Kristopher W Krausz; Frank J Gonzalez; Suman Ranjit; Alexander Dvornikov; Enrico Gratton; Moshe Levi
Journal:  J Am Soc Nephrol       Date:  2017-10-31       Impact factor: 10.121

2.  Deletion of UNC5B in Kidney Epithelium Exacerbates Diabetic Nephropathy in Mice.

Authors:  Punithavathi Ranganathan; Riyaz Mohamed; Calpurnia Jayakumar; Michael W Brands; Ganesan Ramesh
Journal:  Am J Nephrol       Date:  2015-04-16       Impact factor: 3.754

Review 3.  Precision Medicine Approaches to Diabetic Kidney Disease: Tissue as an Issue.

Authors:  Caroline Gluck; Yi-An Ko; Katalin Susztak
Journal:  Curr Diab Rep       Date:  2017-05       Impact factor: 4.810

4.  Tissue-specific metabolic reprogramming drives nutrient flux in diabetic complications.

Authors:  Kelli M Sas; Pradeep Kayampilly; Jaeman Byun; Viji Nair; Lucy M Hinder; Junguk Hur; Hongyu Zhang; Chengmao Lin; Nathan R Qi; George Michailidis; Per-Henrik Groop; Robert G Nelson; Manjula Darshi; Kumar Sharma; Jeffrey R Schelling; John R Sedor; Rodica Pop-Busui; Joel M Weinberg; Scott A Soleimanpour; Steven F Abcouwer; Thomas W Gardner; Charles F Burant; Eva L Feldman; Matthias Kretzler; Frank C Brosius; Subramaniam Pennathur
Journal:  JCI Insight       Date:  2016-09-22

Review 5.  Molecular mechanisms of diabetic kidney disease.

Authors:  Kimberly Reidy; Hyun Mi Kang; Thomas Hostetter; Katalin Susztak
Journal:  J Clin Invest       Date:  2014-06-02       Impact factor: 14.808

Review 6.  The kidney research national dialogue: gearing up to move forward.

Authors:  Joseph V Bonventre; L Ebony Boulware; Laura M Dember; Barry I Freedman; Susan L Furth; Lawrence B Holzman; Christian J Ketchum; Melissa H Little; Rajnish Mehrotra; Sharon M Moe; Jeff M Sands; John R Sedor; Stefan Somlo; Robert A Star; Krystyna E Rys-Sikora
Journal:  Clin J Am Soc Nephrol       Date:  2014-09-15       Impact factor: 8.237

7.  Sacubitril/valsartan treatment has differential effects in modulating diabetic kidney disease in db/db mice and KKAy mice compared with valsartan treatment.

Authors:  Komuraiah Myakala; Bryce A Jones; Xiaoxin X Wang; Moshe Levi
Journal:  Am J Physiol Renal Physiol       Date:  2021-04-19

Review 8.  How to Get Started with Single Cell RNA Sequencing Data Analysis.

Authors:  Michael S Balzer; Ziyuan Ma; Jianfu Zhou; Amin Abedini; Katalin Susztak
Journal:  J Am Soc Nephrol       Date:  2021-03-15       Impact factor: 14.978

9.  Serum amyloid A and inflammation in diabetic kidney disease and podocytes.

Authors:  Robert J Anderberg; Rick L Meek; Kelly L Hudkins; Sheryl K Cooney; Charles E Alpers; Renee C Leboeuf; Katherine R Tuttle
Journal:  Lab Invest       Date:  2014-12-22       Impact factor: 5.662

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.